This video describes the method for synthesizing pure ECM-derived foams without the need for chemical crosslinking. These ECM-derived foams find applications as advanced 3D in vitro cell culture models or as pro-regenerative bioscaffolds.
Protocol
1. ECM-derived Foam Fabrication Prepare the homogenous ECM suspension by dispersing ECM fine powder in buffer solution and incubate at 37 °C with continuous agitation at 120 rpm until the suspension is warm. Dilute the ECM suspension in 0.2 M acetic acidic to the desired concentration. NOTE: Depending on the ECM source, stable foams may be prepared in the range of 10–100 mg/mL, with 15–50 mg/mL as the recommended range for DAT, DDT, and DLV. …
Disclosures
The authors have nothing to disclose.
Materials
Analytical balance
Sartorius
CPA225D
Centrifuge tubes (15 mL)
Sarstedt
62.554.205
Centrifuge tubes (50 mL)
Sarstedt
62.547.205
Collagen from bovine achilles
tendon (insoluble)
Sigma
C9879
Or similar insoluble collagen
source; Can be used as an
alternative to decellularized
tissues to fabricate the foams and
microcarriers
Dessicator
Fisher Scientific
8624426
For lyophilized ECM and
bioscaffold storage
Dewar flask
Fisher Scientific
10-196-6
Low form; volume range of 250 -500 mL
Double distilled water (ddH_{2} O)
From Barnstead GenPure xCAD
Water Purification System
D-PBS (Phosphate-buffered
Saline)
Wisent
311425125
ECM (Extracellular Matrix)
Isolated from human adipose
tissue, porcine dermis or porcine
myocardium, as described in Flynn
et al. 2010, Reing et al. 2010, and
Wainwright et al. 2010 (ref # 28, 8,
32)
Extracellular Matrix-derived Foam Fabrication via Lyophilization: A Procedure to Generate Biological Scaffolds from ECM of Decellularized Tissues. J. Vis. Exp. (Pending Publication), e20485, doi: (2023).